Anti-ageing drugs market seen doubling to $161.8B by 2035

Market Research Future says the global anti-ageing drugs market is set to grow from $84.39 billion in 2026 to $161.80 billion by 2035, driven by aging populations, minimally invasive procedures and e-commerce growth. The forecast points to strong demand in North America and Asia-Pacific, with injectable treatments, device-based therapies and at-home products gaining share.

Why it matters: - The anti-ageing drugs market is projected to nearly double by 2035, signaling durable demand across skincare, injectables and device-based treatments. - Aging populations, lower-cost procedures and digital sales channels are expanding access beyond premium buyers. - The shift matters for dermatology clinics, device makers, consumer brands and investors backing aesthetics and longevity products.

What happened: - Market Research Future estimated the global anti-ageing drugs market at $78.50 billion in 2025. - The firm projected the market will reach $84.39 billion in 2026 and $161.80 billion by 2035, implying a 7.50% CAGR from 2026 to 2035. - The report was published July 16, 2026.

The details: - The United Nations projects people age 65 and older will make up 16% of the global population by 2030, up from 10% in 2022. - The American Society of Plastic Surgeons reported 26.2 million minimally invasive cosmetic procedures in the U.S. in 2023, up 12% year over year. - Hyaluronic-acid fillers, botulinum-toxin injectables and energy-based skin-tightening treatments are the core revenue drivers for dermatology clinics. - Online channels represented about 20% of market distribution in 2025 and are expected to reach 32% by 2035. - Social-commerce platforms in China, led by Douyin and Xiaohongshu, generated more than $6 billion in beauty and personal-care sales in 2024. - Subscription replenishment and AI-driven virtual try-on tools are said to cut customer-acquisition costs by up to 35%. - Request a free sample - Read the detailed report

Between the lines: - The market forecast leans heavily on structural demand rather than discretionary spending. - Government funding and policy support are also reinforcing the category, including the U.S. National Institute on Aging’s $4.2 billion annual research budget and Horizon Europe’s longevity cluster. - Private-equity investment in cosmetic dermatology clinics exceeded $12 billion globally in 2024, suggesting capital is flowing toward scalable, device-driven platforms. - The report’s strongest growth signals cluster around products and procedures that reduce recovery time and broaden access, not traditional surgery. - The forecast also suggests the market is becoming more platform-based, with diagnosis, commerce and treatment increasingly linked through digital tools.

What's next: - Market Research Future expects AI-driven personalization and autonomous diagnostics to influence first-time anti-ageing purchases more heavily by 2030. - The report says integrated beauty-health platforms will become more important as companies combine telehealth, commerce and connected-device data. - Europe and North America are expected to keep high-value demand, while Asia-Pacific remains the fastest-growing region through 2035.

The bottom line: - Anti-ageing is moving from a niche aesthetic category to a broad consumer-health market powered by aging demographics, minimally invasive care and digital retail.